Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 1418-1422.
Article
CAS
PubMed
Google Scholar
Wouters EF: Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003, 97 (Suppl C): S3-14. 10.1016/S0954-6111(03)80020-3.
Article
PubMed
Google Scholar
Poole PJ, Black PN: Systematic review of mucolytics for prevention of exacerbations in chronic bronchitis. BMJ. 2001, 322: 1271-4. 10.1136/bmj.322.7297.1271.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gerrits CM, Herings RM, Leufkens HG, Lammers JW: N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J. 2003, 21: 795-8. 10.1183/09031936.03.00063402.
Article
CAS
PubMed
Google Scholar
Nagy AM, Vanderbist F, Parij N, Maes P, Fondu P, Neve J: Effect of the mucoactive drug Nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulm Pharmacol Ther. 1997, 10: 287-92. 10.1006/pupt.1998.0106.
Article
CAS
PubMed
Google Scholar
Kasielski M, Nowak D: Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med. 2001, 95: 448-56. 10.1053/rmed.2001.1066.
Article
CAS
PubMed
Google Scholar
Blesa S, Cortijo J, Mata M, Serrano A, Closa D, Santangelo F, Estrela JM, Suchankova J, Morcillo EJ: Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen. Eur Respir J. 2003, 21: 394-400.
Article
CAS
PubMed
Google Scholar
Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, Fabbri LM: Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994, 150: 1646-52.
Article
CAS
PubMed
Google Scholar
Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, Bast A: Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996, 154: 813-6.
Article
CAS
PubMed
Google Scholar
Kim S, Nadel JA: Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treat Respir Med. 2004, 3: 147-59.
Article
CAS
PubMed
Google Scholar
Ram FSF, Poole PJ, Bagg W, Stewart J, Black PN: Randomised, controlled trial of theophylline for the treatment of exacerbations of chronic obstructive pulmonary disease (abstract). Am J Respir Crit Care Med. 2000, 161 (Suppl): A489-
Google Scholar
Bonanomi L, Gazzaniga A: Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis Suppl. 1980, 111: 45-51.
CAS
PubMed
Google Scholar
Bridgeman MME, Marsden M, Selby C, Morrison D, MacNee W: Effect of N-acetylcysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax. 1994, 49: 670-675.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bridgeman MME, Marsden M, MacNee W, Flenley DC, Ryle AP: Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after the treatment with N-acetylcysteine. Thorax. 1991, 46: 39-42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast agent- induced reduction in renal function by acetylcysteine. N Engl J Med. 2000, 343: 180-10.1056/NEJM200007203430304.
Article
CAS
PubMed
Google Scholar
Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA. 2003, 289: 553-8. 10.1001/jama.289.5.553.
Article
CAS
PubMed
Google Scholar
Davies L, Angus RM, Calverley PM: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999, 354: 456-60. 10.1016/S0140-6736(98)11326-0.
Article
CAS
PubMed
Google Scholar
Wood-Baker R, Walters EH, Gibson P: Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2001, 2: CD001288-
PubMed
Google Scholar
Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S: Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensates of children with asthma exacerbations. Thorax. 2003, 58: 505-509. 10.1136/thorax.58.6.505.
Article
CAS
PubMed
PubMed Central
Google Scholar
Langlands JHM: Double-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitis. Lancet. 1970, i: 448-450. 10.1016/S0140-6736(70)90835-4.
Article
Google Scholar
Maesen FPV, Davies BI, Brouwers J, Rubingh G: Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. Eur J Respir Dis. 1982, 63: 325-329.
CAS
PubMed
Google Scholar
Finiguerra M, Conti P, Figura I, Legnani W, Morandini GC: Clinical study on the effects of an antibiotic and mucolytic association (amoxicillin and domiodol) in hypersecretory chronic bronchopulmonary diseases. Curr Ther Res. 1982, 31: 895-905.
Google Scholar
Ricevuti G, Mazzone A, Uccelli E, Gazzani G, Fregnan GB: Influence of erdosteine, a mucolytic agent, on amoxicillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis. Thorax. 1988, 43: 585-590.
Article
CAS
PubMed
PubMed Central
Google Scholar